All Publications

1. Files DC, Matthay MA, Calfee CS, Aggarwal NR, Asare AL, Beitler JR, Berger PA, Burnham EL, Cimino G, Coleman MH, Crippa A, Discacciati A, Gandotra S, Gibbs KW, Henderson PT, Ittner CAG, Jauregui A, Khan KT, Koff JL, Lang J, LaRose M, Levitt J, Lu R, McKeehan JD, Meyer NJ, Russell DW, Thomas KW, Eklund M, Esserman LJ, Liu KD, ISPY COVID Adaptive Platform Trial Network, undefined. I-SPY COVID adaptive platform trial for COVID-19 acute respiratory failure: rationale, design and operations. BMJ Open. 2022 06 06; 12(6):e060664. View in PubMed
2. I-SPY COVID Consortium. Clinical trial design during and beyond the pandemic: the I-SPY COVID trial. Nat Med. 2022 01; 28(1):9-11. View in PubMed
3. Coleman MH, Aldrich JM. Acute Respiratory Distress Syndrome: Ventilator Management and Rescue Therapies. Crit Care Clin. 2021 Oct; 37(4):851-866. View in PubMed
4. De Rienzo A, Coleman MH, Yeap BY, Severson DT, Wadowski B, Gustafson CE, Jensen RV, Chirieac LR, Richards WG, Bueno R. Association of RERG Expression with Female Survival Advantage in Malignant Pleural Mesothelioma. Cancers (Basel). 2021 Feb 02; 13(3). View in PubMed
5. Kue RC, Temin ES, Weiner SG, Gates J, Coleman MH, Fisher J, Dyer S. Tourniquet Use in a Civilian Emergency Medical Services Setting: A Descriptive Analysis of the Boston EMS Experience. Prehosp Emerg Care. 2015 Jul-Sep; 19(3):399-404. View in PubMed
6. De Rienzo A, Richards WG, Yeap BY, Coleman MH, Sugarbaker PE, Chirieac LR, Wang YE, Quackenbush J, Jensen RV, Bueno R. Sequential binary gene ratio tests define a novel molecular diagnostic strategy for malignant pleural mesothelioma. Clin Cancer Res. 2013 May 01; 19(9):2493-502. View in PubMed
7. Coleman MH, Bueno R. Role of adjuvant chemotherapy in NSCLC (stages I to III). Surg Oncol Clin N Am. 2011 Oct; 20(4):757-67. View in PubMed
8. Coleman MH, Awad ZT, Pomp A, Gagner M. Laparoscopic closure of the Petersen mesenteric defect. Obes Surg. 2006 Jun; 16(6):770-2. View in PubMed